RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Date:

November 15, 2024

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr. his pick to head the Department of Health and Human Services.

Source link

Heat Today: Bam Adebayo, rest of team eyes early solutions before facing Pacers

General Motors slashes another 1,000 jobs to cut costs

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Recent posts

Oil prices fall after weak China data sparks demand concerns

Trump and Harris spar over fracking amid America’s soaring energy needs

China stimulus plans spark a commodities rally, but a soft landing still isn’t a sure bet

Eli Lilly’s stock soars as Mounjaro, Zepbound sales lead to a big profit beat

Gold’s record-breaking run comes as stocks hit fresh highs. Is it too late for investors?

Hugo Boss shares sink as company becomes latest fashion seller to cut guidance

Hurricane Beryl puts focus on oil with climate change likely to intensify storms

J&J to acquire V-Wave for up to $1.7 billion in play for heart-failure device

Trump floats manufacturing ambassador, while his Deere tariff threat draws flak from Mark Cuban

Commodity markets fear a repeat of China’s 2015 economic slowdown

Consumer stocks made a comeback in June — but U.S. households are still feeling the pinch

Levi’s sales miss expectations, and jeans maker forecasts higher costs for marketing and logistics

This week’s U.S. inflation report could have serious implications for stocks

Here’s how stocks have performed under Biden and Harris vs. under Trump

Bud Light sales extend their drop but Michelob Ultra takes up some slack: report

Related articles

Investors are bracing for higher-for-even-longer interest rates

Manufacturing activity surges in New York region to highest level in nearly three years

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Off-price retailers could thrive, BofA says, citing this bullish data point

Republicans clinch control of House, setting stage for quicker action on extending tax cuts

Company

Follow us